№ files_lp_4_process_3_112214
File format: docx
Character count: 60834
File size: 116 KB
Application for official membership in the OPTN by hospitals seeking authorization to perform lung transplants, detailing administrative and medical staff, qualifications, and certification requirements.
Year:
2026
Organization:
Organ Procurement and Transplantation Network (OPTN)
Type of Document:
Membership Application
Program Type:
Lung Transplant Program
Intended Audience:
Transplant Hospitals and Physicians
Submission Date:
2026-03-14
Responsible Parties:
Program Director, Primary Surgeon, Primary Physician, Primary Data Coordinator, Primary Program Administrator
Certification Requirement:
True and complete information attested by authorized representative
Pediatric Component:
Optional, indicated if applicable
Compliance:
Subject to OPTN obligations and Department of Health and Human Services regulations
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
United States
Topic:
Organ procurement and transplantation
Document Type:
Membership application
Organization / Institution:
Organ Procurement and Transplantation Network (OPTN)
Author:
Applicant organization representative
Target Audience:
Organ Procurement Organizations (OPOs)
Effective Period:
Upon submission and approval
Submission Date:
2026-02-28
Required Attachments:
QAPI plan, resumes of administrative and medical directors, agreements with hospitals and laboratories
Legal Compliance:
Adherence to Code of Federal Regulations and OPTN obligations
Insurance Coverage:
Minimum professional liability of $1,000,000
Year:
2023
Region / city:
United States
Topic:
Liver Transplant Program Membership Application
Document Type:
Certification Form
Organization / Institution:
OPTN
Author:
United Network for Organ Sharing (UNOS)
Target Audience:
Medical Institutions, Transplant Programs
Period of validity:
Indefinite
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / City:
United States
Theme:
Transplantation
Document Type:
Instructional Guidelines
Organ / Institution:
OPTN
Author:
Not specified
Target Audience:
Healthcare providers, transplant centers
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Institution:
University of California, Los Angeles (UCLA)
Medical specialty:
Cardiology and Transplant Medicine
Clinical focus:
Pre-cardiac transplant patients
Assessment type:
Frailty and geriatric evaluation
Patient population:
Hospitalized heart transplant candidates
Frailty models referenced:
Fried Frailty Phenotype; Short Physical Performance Battery
Components assessed:
Physical frailty; Functional status; Mood; Cognitive function
Functional measures:
Activities of Daily Living (Katz ADL)
Mood measure:
Geriatric Depression Scale (GDS-5)
Cognitive measure:
Mini-Cog
Physical tests included:
Weight loss; Exhaustion; Physical activity; Chair rise; Balance test; Gait speed; Grip strength
Scoring systems:
Fried Frailty scoring; SPPB scoring
Intended users:
Clinical trainees and research assistants
Associated institution contact:
UCLA Ronald Reagan Medical Center
Associated clinician:
Ben Seligman, MD
Source type:
Clinical assessment protocol and standardized evaluation form
Title:
Activity 4.3.1 Student Resource Sheet
Subject:
Organ transplantation ethics
Topic:
Kidney transplant allocation scenarios
Document Type:
Educational resource sheet
Intended Audience:
Students
Number of Scenarios:
Thirteen
Medical Focus:
Kidney transplantation
Key Themes:
Allocation criteria, medical urgency, waiting time, age, social factors, financial status
Organizations Mentioned:
Organ procurement organization (OPO)
Health Conditions Referenced:
HIV, type 1 diabetes, acute lymphocytic leukemia (ALL), schizophrenia, ovarian cancer
Geographic Scope:
Not specified
Publication Date:
Not specified
Year:
2015
Journal:
Nat Sci
Volume:
13
Issue:
1
Pages:
45-48
ISSN:
1545-0740
Author:
Dr. Ghazal Norouzi
Author Affiliation:
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Institution:
Imam Hussain (AS) Hospital, Tehran, Iran
Study Period:
2009-2013
Study Design:
Retrospective descriptive analytical study
Sample Size:
215 patients
Follow-up Duration:
24 months
Field:
Ophthalmology
Keywords:
Corneal Transplantation; Penetrating Keratoplasty; Graft Rejection; Risk Factors
Language:
English
Note:
Year
Organ / Institution:
Malaysian Society of Nephrology
Remarks:
The document outlines the procedures for registering a transplant center and its staff with the Malaysian Kidney Allocation System (MyKAS), including responsibilities and data protection requirements for accessing the National Active Waiting Listing.
Year:
2022
Region / City:
Detroit
Topic:
Transplantation, Pancreas
Document Type:
Educational Lecture
Institution:
Henry Ford Health System
Author:
Not listed
Target Audience:
Transplant Institute Faculty
Period of Validity:
8/29/2022
Approval Date:
12/28/2021
Date of Updates:
08/01/2022
Accreditation:
Accredited by ACCME
Maximum Credit:
1.00 AMA PRA Category 1 Credit(s)™
Faculty Disclosure:
All relevant financial relationships have been mitigated
Accessibility:
Accessible for individuals with disabilities
Context:
Educational lecture providing an update on pancreas transplantation, focusing on federal regulations, quality initiatives, research findings, cancer in transplantation, and transplantation in the COVID era.
Year:
2021
Region / City:
Dublin
Topic:
Organ donation and transplantation
Document type:
Job specification
Organization:
Organ Donation Transplant Ireland (ODTI)
Author:
N/A
Target audience:
Healthcare professionals, job seekers in the healthcare sector
Period of validity:
Until position is filled
Approval date:
N/A
Date of changes:
N/A
Year:
2021
Region:
New Zealand
Topic:
Kidney Transplantation
Document Type:
Report
Author:
Nick Cross, Clinical Director, National Renal Transplant Service
Target Audience:
Healthcare professionals, policy makers, and researchers in renal transplantation
Date of Approval:
21 March 2022
Date of Last Update:
N/A
Period of Activity:
2021
Data Source:
Australian and New Zealand Dialysis and Transplantation Registry (ANZDATA), New Zealand Blood and Organ Service
Transplant Centers:
Auckland, Wellington, Christchurch
COVID-19 Impact:
Yes
Ethnicity Data Included:
Yes
Population:
5.12 million (as of June 2021)
Date:
29 March 2019
Time:
9.45 am – 3.00 pm
Location:
Ministry of Health, 133 Molesworth Street, Wellington
Attendees:
Nick Cross (Chair), Ian Dittmer, Jane Potiki, Jane Presto, John Irvine, John Schollum, Kristin Wilson, Philip Matheson, Ralph La Salle, Claire Beckett, Stephen Munn, Sue Townsend
Apologies:
Justin Roake, Denise Beechey, Dilip Naik
Year:
2019
Region / City:
Wellington
Theme:
Renal Transplantation
Document Type:
Meeting Minutes
Organization / Institution:
Ministry of Health
Author:
Sue Townsend (Minutes Secretary)
Target Audience:
Transplant professionals, renal physicians, healthcare administrators
Action Period:
March 2019 – ongoing discussions
Approval Date:
29 March 2019
Date of Changes:
None noted
Year:
2024
Organization:
Health and Human Services Department
Author:
Lisa Marrow
Instructor:
T.J. Shaw
Type of Document:
Case Study
Region:
United States
Target Audience:
Operational and financial management teams
Focus Area:
Staffing and supply management
Period Covered:
Fiscal Year 2024
Reference Materials:
HTHS230 Week Two Lectures, www.Med.unc.edu
Note:
, www.Kantata.com
Document Purpose:
Analysis of budget shortfalls and proposed operational improvements
Year:
Not specified
Disease:
Acute Myeloid Leukemia (AML)
Genetic Focus:
FLT3 mutations (TKD, ITD, ITD-TKD)
Treatment Groups:
FLT3 inhibitors (FLT3i) vs Conventional Chemotherapy (CT)
Endpoints:
Overall Survival (OS); Event-Free Survival (EFS); Time to Transplant
Study Period:
Before and after 2018 approval of FLT3 inhibitors
Statistical Methods:
Logistic regression; Propensity score weighting; Inverse probability weighting; Cox proportional hazard models; Mediation analysis; Sensitivity analysis
Confounders Considered:
Sex; Age; AML type; FLT3 mutation type; White-blood cell count; Platelet count; ELN risk classification; Ongoing comorbidities
Risk Classification System:
European LeukemiaNet (ELN)
Supplementary Material:
Table S1 (subgroup analyses with inverse probability weighting); Table S2 (baseline characteristic survival analyses)
Key Measures:
Hazard Ratios (HR); 95% Confidence Intervals (CI); p-values
Regulatory Milestone Referenced:
Clinical approval of FLT3 inhibitors in 2018
Year:
2004
Region / City:
Nationwide
Topic:
Healthcare, Solid Organ Transplantation
Document Type:
Service Specification
Organization:
Ministry of Health
Author:
Not specified
Target Audience:
Healthcare professionals and service providers
Period of Validity:
Until next review within five years
Approval Date:
April 2004
Amendments Date:
9 April 2014, June 2020
Year:
2013-present
Region / City:
Duhok, Kurdistan Region, Iraq
Subject:
Urology, Surgery, Medical Education
Document Type:
Professional Curriculum Vitae
Organization / Institution:
Azadi Teaching Hospital, University of Duhok
Author:
Dr. Nashwan Mohammed Rasheed Ibrahim
Target Audience:
Medical professionals, academic institutions, health organizations
Period of Validity:
Ongoing
Approval Date:
N/A
Modification Date:
N/A
Year:
2023
Region / city:
UK
Theme:
Oncology, Lung Cancer, Treatment Guidelines
Document type:
Clinical guidelines
Organization / institution:
NICE
Author:
NICE
Target audience:
Healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Contextual description:
Detailed clinical guidelines outlining the recommended systemic treatments for advanced non-small-cell lung cancer based on disease progression and previous therapies.
Service:
Lung Cancer Whole Pathway
Document type:
Commissioning guidance
Health system:
NHS England
Period:
2024/25
Date of review:
April 2026
Scope:
Direct and specialised commissioning
Clinical focus:
Lung cancer
Geographical context:
United Kingdom
Policy context:
NHS Long Term Plan
Related pathway:
National Optimal Lung Cancer Pathway
Commissioning themes:
Early diagnosis, reducing variation, living with cancer
Evidence base:
NICE guidance and national standards
Note:
Year
Topic:
Lung disease, steroid treatment
Document type:
Information sheet
Organization / institution:
Sheffield Teaching Hospitals NHS Foundation Trust
Author:
Respiratory and endocrinology teams
Target audience:
People with lung disease on high dose inhaled steroids